{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT06943469",
      "orgStudyIdInfo": {
        "id": "2215INF"
      },
      "organization": {
        "fullName": "Société des Produits Nestlé (SPN)",
        "class": "INDUSTRY"
      },
      "briefTitle": "Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function",
      "officialTitle": "Synbiotics in Partially Hydrolysed Formula for Improved skiN Barrier Function in Infants at Risk for Allergy (SPHINX Study)",
      "acronym": "SPHINX"
    },
    "statusModule": {
      "statusVerifiedDate": "2025-12",
      "overallStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2025-04-10",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2027-10",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2028-11",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2025-03-17",
      "studyFirstSubmitQcDate": "2025-04-16",
      "studyFirstPostDateStruct": {
        "date": "2025-04-24",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2025-12-11",
      "lastUpdatePostDateStruct": {
        "date": "2025-12-12",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Société des Produits Nestlé (SPN)",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": false
    },
    "descriptionModule": {
      "briefSummary": "The main purpose of this study is to assess the efficacy of a partially hydrolyzed formula with synbiotics in halting one of the first steps of the allergic march (atopic dermatitis) in infants at risk of allergy. Other efficacy and safety parameters will be assessed as well."
    },
    "conditionsModule": {
      "conditions": [
        "Atopic Dermatitis (AD)"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "OTHER",
        "maskingInfo": {
          "masking": "QUADRUPLE",
          "whoMasked": [
            "PARTICIPANT",
            "CARE_PROVIDER",
            "INVESTIGATOR",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 400,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Test formula",
          "type": "EXPERIMENTAL",
          "description": "Partially hydrolyzed formula with synbiotics",
          "interventionNames": [
            "Other: Test formula"
          ]
        },
        {
          "label": "Control formula",
          "type": "ACTIVE_COMPARATOR",
          "description": "Intact protein formula without synbiotics",
          "interventionNames": [
            "Other: Control formula"
          ]
        },
        {
          "label": "Reference arm",
          "type": "NO_INTERVENTION",
          "description": "Breastfed arm (not applicable for France)"
        }
      ],
      "interventions": [
        {
          "type": "OTHER",
          "name": "Test formula",
          "description": "Partially hydrolyzed formula with synbiotics",
          "armGroupLabels": [
            "Test formula"
          ]
        },
        {
          "type": "OTHER",
          "name": "Control formula",
          "description": "Intact protein formula without synbiotics",
          "armGroupLabels": [
            "Control formula"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "TransEpidermal Water Loss (TEWL) at 3 months",
          "description": "TransEpidermal water loss will be measured using a validated non-invasive technique.",
          "timeFrame": "At 3 months of age"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Cumulative incidence of Atopic Dermatitis",
          "description": "Cumulative incidence of AD is based on physician diagnosis using the United Kingdom Working Party (UKWP) diagnosis criteria.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "TransEpidermal Water Loss",
          "description": "Epidermal water loss will be measured using a validated non-invasive technique.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Skin surface (stratum corneum) hydration",
          "description": "Skin hydration will be measured with a corneometer device.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Extent and severity of Atopic Dermatitis",
          "description": "SCORAD (SCORing for Atopic Dermatitis), scores range from 0 to 103, with higher scores indicating higher atopic dermatitis severity",
          "timeFrame": "From 3 months to 12 months of age"
        },
        {
          "measure": "Cumulative use of topical steroids and calcineurin inhibitors",
          "description": "Use of medication to treat AD and other symptoms will be collected via parent self-reported questionnaire.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Skin cytokines",
          "description": "Concentration of skin cytokines such as IL4 and IL5 using immunoassays",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Skin natural moisturizing factors",
          "description": "Concentration of skin natural moisturizing factors such as Pyrrolidone carboxylic acid, using HPLC",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Skin stratum corneum lipids",
          "description": "Concentration of skin stratum corneum lipids such as ceramides, cholesterol and triacylglycerol using mass spectrometry",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Skin microbiome",
          "description": "Overall skin microbiome composition and diversity using next-generation sequencing",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Skin metabolites",
          "description": "Levels of skin metabolites using targeted or untargeted approaches.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Immune proteomics",
          "description": "Levels of plasma proteins using mass cytometry or immunoassaysand immunoassays.",
          "timeFrame": "From enrollment to 6 months of age"
        },
        {
          "measure": "Immune blood cell immunophenotyping",
          "description": "Levels of immune cell populations using mass cytometry or immunoassays",
          "timeFrame": "From enrollment to 6 months of age"
        },
        {
          "measure": "Specific IgE antibodies",
          "description": "Specific IgE antibodies will be measured using Phadiatop infant®.",
          "timeFrame": "At 12 months of age"
        },
        {
          "measure": "Fecal microbiome",
          "description": "Overall fecal microbiota composition, diversity, different bacteria taxa and microbiota community types assessed using next generation sequencing (NGS) technology",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Fecal metabolites",
          "description": "Levels of fecal metabolites using targeted or untargeted approaches.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Fecal biomarkers of inflammation and immunity",
          "description": "Levels of fecal markers of immune health and inflammation such as total secretory IgA (sIgA), calprotectin, and α-1-antitrypsin assessed by ELISA.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Physician-diagnosed allergic manifestations",
          "description": "Number of participants with Physician-diagnosed allergic manifestations.",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Gastrointestinal tolerance",
          "description": "Infant Gastrointestinal Symptom Questionnaire (IGSQ), scores range from 13 to 65, with higher scores indicating higher gastrointestinal discomfort.",
          "timeFrame": "At enrollment and 4 months of age"
        },
        {
          "measure": "Weight",
          "description": "Weight (g and z-scores)",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Height",
          "description": "Length (cm and z-scores)",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Head circumference",
          "description": "Head circumference (cm and z-scores)",
          "timeFrame": "From enrollment to 12 months of age"
        },
        {
          "measure": "Safety assessment",
          "description": "Incidence of adverse events",
          "timeFrame": "From enrollment to 13 months of age"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n1. Written informed consent has been obtained from at least one parent or legally acceptable representative (LAR), if applicable\n2. Infant gestational age ≥ 37 completed weeks\n3. Infant birth weight of ≥ 2.5 kg and ≤ 4.5 kg\n4. Infant postnatal age ≤ 14 days (date of birth = day 0) at enrollment\n5. Infant from singleton birth or infant from multiple births may if all birth siblings are enrolled.\n6. At least one biological parent or sibling has (or had) a medically diagnosed history of allergy, based on response to a simple screening questionnaire\n7. a. For the breastfed reference group only: infant is exclusively breastfed since birth with no intake of formula, and their parent(s) have the intention to continue exclusive breastfeeding until at least 4 months of age.\n\n   or b. For the randomized formula-fed groups only: infant is exclusively or predominantly formula-fed in the 24 hours prior to enrollment, with formula feeding representing at least 75% of total daily feeds. The decision to introduce formula feeding was independently made by the parents before enrollment.\n8. Parents/LAR must be able to provide evidence of parental authority and identity.\n9. Infant's parent(s)/LAR must understand the informed consent form and other study documents and are willing and able to fulfill the requirements of the study protocol.\n\nExclusion Criteria:\n\n1. Infectious, metabolic, congenital, genetic, gastrointestinal illness or any other condition (e.g., gastrointestinal surgery) that could impact oral feeding, growth or study outcomes.\n2. Infants with special dietary needs other than standard infant formula (e.g., extensively hydrolyzed formula, amino acid formula, special formula for metabolic diseases) or requiring tube feeding.\n3. Infant has already been diagnosed with allergy by a physician, including AD and/or cow's milk allergy.\n4. Infant is currently participating or has previously participated in another clinical trial prior to enrollment.\n5. Infant's parents or LARs have not reached legal age of majority (18 years).",
      "healthyVolunteers": true,
      "sex": "ALL",
      "minimumAge": "1 Day",
      "maximumAge": "14 Days",
      "stdAges": [
        "CHILD"
      ]
    },
    "contactsLocationsModule": {
      "centralContacts": [
        {
          "name": "Amelie Goyer, PhD",
          "role": "CONTACT",
          "phone": "+41217858939",
          "email": "Amelie.Goyer1@rd.nestle.com"
        }
      ],
      "locations": [
        {
          "facility": "AZ Sint-Jan Brugge-Oostende AV - Campus Sint-Jan",
          "status": "RECRUITING",
          "city": "Bruges",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Luc Cornette, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 51.20892,
            "lon": 3.22424
          }
        },
        {
          "facility": "Universitair Ziekenhuis Brussel - Kinderziekenhuis",
          "status": "RECRUITING",
          "city": "Brussels",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Yvan Vandenplas, Pr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 50.85045,
            "lon": 4.34878
          }
        },
        {
          "facility": "Clinique Ste Elisabeth",
          "status": "RECRUITING",
          "city": "Namur",
          "country": "Belgium",
          "contacts": [
            {
              "name": "Sabine Jespers, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 50.4669,
            "lon": 4.86746
          }
        },
        {
          "facility": "CHU Amiens Picardie",
          "status": "RECRUITING",
          "city": "Amiens",
          "country": "France",
          "contacts": [
            {
              "name": "André Léké, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 49.9,
            "lon": 2.3
          }
        },
        {
          "facility": "CHU de Caen",
          "status": "RECRUITING",
          "city": "Caen",
          "country": "France",
          "contacts": [
            {
              "name": "Geraldine Favrais, Pr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 49.18585,
            "lon": -0.35912
          }
        },
        {
          "facility": "CHU de Grenoble Alpes",
          "status": "RECRUITING",
          "city": "Grenoble",
          "country": "France",
          "contacts": [
            {
              "name": "Blandine Rébeillé Borgella",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 45.17869,
            "lon": 5.71479
          }
        },
        {
          "facility": "Hôpital de la Croix Rousse",
          "status": "RECRUITING",
          "city": "Lyon",
          "country": "France",
          "contacts": [
            {
              "name": "Jean-Charles Picaud, Pr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 45.74906,
            "lon": 4.84789
          }
        },
        {
          "facility": "Hôpital Charles Nicolle",
          "status": "RECRUITING",
          "city": "Rouen",
          "country": "France",
          "contacts": [
            {
              "name": "Mireille Castanet, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 49.44313,
            "lon": 1.09932
          }
        },
        {
          "facility": "CHRU de Tours",
          "status": "RECRUITING",
          "city": "Tours",
          "country": "France",
          "contacts": [
            {
              "name": "Kristen Joseph-Delaffon, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 47.39484,
            "lon": 0.70398
          }
        },
        {
          "facility": "Charite-Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK)",
          "status": "NOT_YET_RECRUITING",
          "city": "Berlin",
          "country": "Germany",
          "contacts": [
            {
              "name": "Kirsten Beyer, Pr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Evangelisches Krankenhaus Düsseldorf - Frauenklinik",
          "status": "RECRUITING",
          "city": "Düsseldorf",
          "country": "Germany",
          "contacts": [
            {
              "name": "Monika Gappa, Pr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 51.22172,
            "lon": 6.77616
          }
        },
        {
          "facility": "Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Frankfurt",
          "status": "RECRUITING",
          "city": "Frankfurt",
          "country": "Germany",
          "contacts": [
            {
              "name": "Katharina Bluemchen, PD Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 49.68333,
            "lon": 10.53333
          }
        },
        {
          "facility": "Evangelisches Waldkrankenhaus Spandau",
          "status": "RECRUITING",
          "city": "Spandau",
          "country": "Germany",
          "contacts": [
            {
              "name": "Frank Jochum, PD Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 52.5511,
            "lon": 13.19921
          }
        },
        {
          "facility": "Marien Hospital Wesel GmbH",
          "status": "NOT_YET_RECRUITING",
          "city": "Wesel",
          "country": "Germany",
          "contacts": [
            {
              "name": "Cordula Koerner-Rettberg, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 51.6669,
            "lon": 6.62037
          }
        },
        {
          "facility": "Hospital Teresa Herrera",
          "status": "RECRUITING",
          "city": "A Coruña",
          "country": "Spain",
          "contacts": [
            {
              "name": "Ana Moreno Álvarez, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 43.37135,
            "lon": -8.396
          }
        },
        {
          "facility": "HU Torrecárdenas",
          "status": "RECRUITING",
          "city": "Almería",
          "country": "Spain",
          "contacts": [
            {
              "name": "Rafael Galera Martínez, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 36.83814,
            "lon": -2.45974
          }
        },
        {
          "facility": "Hospital Quiron Salud Barcelona",
          "status": "RECRUITING",
          "city": "Barcelona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Hector Boix, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.38879,
            "lon": 2.15899
          }
        },
        {
          "facility": "Hospital Universitario Severo Ochoa",
          "status": "RECRUITING",
          "city": "Madrid",
          "country": "Spain",
          "contacts": [
            {
              "name": "Maria Luz Garcia, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 40.4165,
            "lon": -3.70256
          }
        },
        {
          "facility": "Grupo Pediátrico Uncibay",
          "status": "RECRUITING",
          "city": "Málaga",
          "country": "Spain",
          "contacts": [
            {
              "name": "Manuel Ramón Baca Cots, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 36.72016,
            "lon": -4.42034
          }
        },
        {
          "facility": "Instituto Hispalense de Pediatria (IHP)",
          "status": "RECRUITING",
          "city": "Seville",
          "country": "Spain",
          "contacts": [
            {
              "name": "Ignacio Salamanca de la Cueva, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 37.38283,
            "lon": -5.97317
          }
        },
        {
          "facility": "Hospital Universitari de Tarragona Joan XXIII",
          "status": "RECRUITING",
          "city": "Tarragona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Esther Parada Ricart, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.11905,
            "lon": 1.24544
          }
        },
        {
          "facility": "Hospital Universitari Sant Joan de Reus",
          "status": "RECRUITING",
          "city": "Tarragona",
          "country": "Spain",
          "contacts": [
            {
              "name": "Joaquín Escribano Subias, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.11905,
            "lon": 1.24544
          }
        },
        {
          "facility": "HCU Lozano Blesa",
          "status": "RECRUITING",
          "city": "Zaragoza",
          "country": "Spain",
          "contacts": [
            {
              "name": "Gerardo Rodríguez Martínez, Dr",
              "role": "CONTACT"
            }
          ],
          "geoPoint": {
            "lat": 41.65606,
            "lon": -0.87734
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D003876",
          "term": "Dermatitis, Atopic"
        }
      ],
      "ancestors": [
        {
          "id": "D012873",
          "term": "Skin Diseases, Genetic"
        },
        {
          "id": "D030342",
          "term": "Genetic Diseases, Inborn"
        },
        {
          "id": "D009358",
          "term": "Congenital, Hereditary, and Neonatal Diseases and Abnormalities"
        },
        {
          "id": "D003872",
          "term": "Dermatitis"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        },
        {
          "id": "D017443",
          "term": "Skin Diseases, Eczematous"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": false
}